Journal article · 2024
Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study
The Lancet Infectious Diseases, 24(8), 817–828 · Published 30 April 2024 · DOI 10.1016/s1473-3099(24)00215-9
In brief
“Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study” is a 2024 journal article by Sonia Ares‐Gómez and 21 co-authors, published in The Lancet Infectious Diseases. OpenAlex counts 327 citations as of 18 November 2026, which puts it in the top 1% of works published in 2024 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 327
- Most cited in
- 2025 (150)
- Field-weighted impact
- 77.86
- References
- 15
- Authors
- 22
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Ares‐Gómez, S., Mallah, N., Santiago-Pérez, M.-I., Pardo‐Seco, J., Martínez, O. P., Otero‐Barrós, M., Súarez‐Gaiche, N., Kramer, R., Jin, J., Platero-Alonso, L., Álvarez-Gil, R., Ces‐Ozores, O., Nartallo‐Penas, V., Mirás‐Carballal, S., Piñeiro-Sotelo, M., Malvar‐Pintos, A., González‐Pérez, J., Rodríguez-Tenreiro, C., Calle, I. R., . . . Martinón‐Torres, F. (2024). Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study. The Lancet Infectious Diseases, 24(8), 817–828. https://doi.org/10.1016/s1473-3099(24)00215-9
MLA 9
Ares‐Gómez, Sonia, et al. “Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study.” The Lancet Infectious Diseases, vol. 24, no. 8, 2024, pp. 817–828. https://doi.org/10.1016/s1473-3099(24)00215-9.
Chicago
Ares‐Gómez, Sonia, Narmeen Mallah, María-Isolina Santiago-Pérez, Jacobo Pardo‐Seco, Olaia Pérez Martínez, María‐Teresa Otero‐Barrós, Nuria Súarez‐Gaiche, et al. 2024. “Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study.” The Lancet Infectious Diseases 24 (8): 817–828. https://doi.org/10.1016/s1473-3099(24)00215-9.
Harvard
Ares‐Gómez, S. et al. (2024) ‘Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study’, The Lancet Infectious Diseases, 24(8), pp. 817–828. doi:10.1016/s1473-3099(24)00215-9.
IEEE
S. Ares‐Gómez et al., “Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study,” The Lancet Infectious Diseases, vol. 24, no. 8, pp. 817–828, 2024, doi: 10.1016/s1473-3099(24)00215-9.
BibTeX
@article{aresgomez2024effectiveness,
title = {{Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study}},
author = {Ares‐Gómez, Sonia and Mallah, Narmeen and Santiago-Pérez, María-Isolina and Pardo‐Seco, Jacobo and Martínez, Olaia Pérez and Otero‐Barrós, María‐Teresa and Súarez‐Gaiche, Nuria and Kramer, Rolf and Jin, Jing and Platero-Alonso, Leticia and Álvarez-Gil, Rosa and Ces‐Ozores, Olga‐María and Nartallo‐Penas, Victoria and Mirás‐Carballal, Susana and Piñeiro-Sotelo, Marta and Malvar‐Pintos, Alberto and González‐Pérez, Juan‐Manuel and Rodríguez-Tenreiro, Carmen and Calle, Irene Rivero and Salas, Antonio and Durán‐Parrondo, Carmen and Martinón‐Torres, Federico},
journal = {The Lancet Infectious Diseases},
year = {2024},
volume = {24},
number = {8},
pages = {817--828},
doi = {10.1016/s1473-3099(24)00215-9},
url = {https://doi.org/10.1016/s1473-3099(24)00215-9}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2024 | 69 | |
| 2025 | 150 | |
| 2026 | 108 |
Its field-weighted citation impact is 77.86: it has been cited 77.86 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
- nirsevimab
- respiratory syncytial virus
- universal prophylaxis
- infants
- lower respiratory tract infection
- immunization programs
- catch-up vaccination
- high-risk infants
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Ares‐Gómez, S., Mallah, N., Santiago-Pérez, M.-I., Pardo‐Seco, J., Martínez, O. P., Otero‐Barrós, M., Súarez‐Gaiche, N., Kramer, R., Jin, J., Platero-Alonso, L., Álvarez-Gil, R., Ces‐Ozores, O., Nartallo‐Penas, V., Mirás‐Carballal, S., Piñeiro-Sotelo, M., Malvar‐Pintos, A., González‐Pérez, J., Rodríguez-Tenreiro, C., Calle, I. R., . . . Martinón‐Torres, F. (2024). Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study. The Lancet Infectious Diseases, 24(8), 817–828. https://doi.org/10.1016/s1473-3099(24)00215-9
How many times has this paper been cited?
327 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Sonia Ares‐Gómez, Narmeen Mallah, María-Isolina Santiago-Pérez, Jacobo Pardo‐Seco, Olaia Pérez Martínez, María‐Teresa Otero‐Barrós, Nuria Súarez‐Gaiche, Rolf Kramer, Jing Jin, Leticia Platero-Alonso, Rosa Álvarez-Gil, Olga‐María Ces‐Ozores and 10 more.
What is the DOI of this paper?
10.1016/s1473-3099(24)00215-9, permanently at https://doi.org/10.1016/s1473-3099(24)00215-9. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.